|
Although PCR are still considered as the “Gold standard” for diagnosing current COVID-19 infections, antigen testing is a suitable ‘first line of defense’ test against COVID-19 due to its relatively simple and quicker procedure.
To support the increasing antigen test requirements and related reagents R&D, ACROBiosystems can now provide high-sensitivity anti-SARS-CoV-2 antibody pairs with following advantages:
- Can effectively detect almost all dominant variants including Omicron;
-
High sensitivity: the sensitivity of detecting WT and VOCs is 0.39 ng/mL;
-
High specificity, no cross-reaction with five other coronaviruses,
-
Good supply Ability: grams of antibodies are now in stock;
-
Free technology transfer: mature colloidal gold reagent development process has been successfully established using these antibodies, which can now be provided free of charge!
| 
